Trial Outcomes & Findings for Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms (NCT NCT05145257)

NCT ID: NCT05145257

Last Updated: 2025-01-01

Results Overview

Survey-based assessment (0-5 scale) of changes in premenstrual cramps. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

68 participants

Primary outcome timeframe

Baseline, Month 1, Month 2, Month 3

Results posted on

2025-01-01

Participant Flow

Main recruitment took place between 1/5/2022 - 1/10/2022 when 65 participants were recruited. A further 3 participants were recruited on 01/26/2022.

Participant milestones

Participant milestones
Measure
Elix Cycle Balance
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Overall Study
STARTED
68
Overall Study
COMPLETED
61
Overall Study
NOT COMPLETED
7

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Elix Cycle Balance
n=68 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Age, Continuous
31 years
STANDARD_DEVIATION 5.07 • n=68 Participants
Sex: Female, Male
Female
68 Participants
n=68 Participants
Sex: Female, Male
Male
0 Participants
n=68 Participants
Survey-based assessment (0-5 scale) of menstrual symptoms
4.07 units on a scale
STANDARD_DEVIATION 0.49 • n=68 Participants
Use of over-the-counter NSAIDS in the Treatment of Primary Dysmenorrhea Symptoms.
2.17 Number of painkillers taken per day
STANDARD_DEVIATION 0.16 • n=68 Participants

PRIMARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in premenstrual cramps. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Premenstrual Cramps [Time Frame: Baseline to 3 Months]
Baseline
4.41 score on a scale
Standard Deviation 1.10
Relief From Premenstrual Cramps [Time Frame: Baseline to 3 Months]
Month 1
3.48 score on a scale
Standard Deviation 1.18
Relief From Premenstrual Cramps [Time Frame: Baseline to 3 Months]
Month 2
3.12 score on a scale
Standard Deviation 1.14
Relief From Premenstrual Cramps [Time Frame: Baseline to 3 Months]
Month 3
2.72 score on a scale
Standard Deviation 1.09

PRIMARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in menstrual cramps. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Menstrual Cramps During the Period [Time Frame: Baseline to 3 Months]
Baseline
5.00 score on a scale
Standard Deviation 0.92
Relief From Menstrual Cramps During the Period [Time Frame: Baseline to 3 Months]
Month 1
3.95 score on a scale
Standard Deviation 1.31
Relief From Menstrual Cramps During the Period [Time Frame: Baseline to 3 Months]
Month 2
3.30 score on a scale
Standard Deviation 1.24
Relief From Menstrual Cramps During the Period [Time Frame: Baseline to 3 Months]
Month 3
3.02 score on a scale
Standard Deviation 1.30

PRIMARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment to assess the change in the number of over-the-counter NSAIDS used from baseline to 12 weeks. Participants were presented with the following options: 1 a day, 2 a day, 3 a day, 4+ a day. A lower score indicates a better outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Reduction in Usage of OTC NSAIDS in the Treatment of Primary Dysmenorrhea Symptoms. [Time Frame: Baseline to 3 Months]
Baseline
2.05 NSAID tablets per day
Standard Deviation 0.16
Reduction in Usage of OTC NSAIDS in the Treatment of Primary Dysmenorrhea Symptoms. [Time Frame: Baseline to 3 Months]
Month 1
1.32 NSAID tablets per day
Standard Deviation 0.06
Reduction in Usage of OTC NSAIDS in the Treatment of Primary Dysmenorrhea Symptoms. [Time Frame: Baseline to 3 Months]
Month 2
1.07 NSAID tablets per day
Standard Deviation 0.13
Reduction in Usage of OTC NSAIDS in the Treatment of Primary Dysmenorrhea Symptoms. [Time Frame: Baseline to 3 Months]
Month 3
0.86 NSAID tablets per day
Standard Deviation 0.03

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in mood swings. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Reduction in Mood Swings. [Time Frame: Baseline to Week 12]
Baseline
4.59 score on a scale
Standard Deviation 1.01
Reduction in Mood Swings. [Time Frame: Baseline to Week 12]
Month 1
3.36 score on a scale
Standard Deviation 1.19
Reduction in Mood Swings. [Time Frame: Baseline to Week 12]
Month 2
3.15 score on a scale
Standard Deviation 1.29
Reduction in Mood Swings. [Time Frame: Baseline to Week 12]
Month 3
2.75 score on a scale
Standard Deviation 1.41

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in anxiety and depression. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Feelings of Anxiety and Depression. [Time Frame: Baseline to Month 3]
Baseline
4.36 score on a scale
Standard Deviation 1.20
Feelings of Anxiety and Depression. [Time Frame: Baseline to Month 3]
Month 1
3.59 score on a scale
Standard Deviation 1.38
Feelings of Anxiety and Depression. [Time Frame: Baseline to Month 3]
Month 2
3.15 score on a scale
Standard Deviation 1.40
Feelings of Anxiety and Depression. [Time Frame: Baseline to Month 3]
Month 3
2.84 score on a scale
Standard Deviation 1.37

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in acne flare ups. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Acne Flare-ups. [Time Frame: Baseline to Month 3]
Baseline
3.74 score on a scale
Standard Deviation 1.41
Relief From Acne Flare-ups. [Time Frame: Baseline to Month 3]
Month 1
3.02 score on a scale
Standard Deviation 1.35
Relief From Acne Flare-ups. [Time Frame: Baseline to Month 3]
Month 2
2.51 score on a scale
Standard Deviation 1.35
Relief From Acne Flare-ups. [Time Frame: Baseline to Month 3]
Month 3
2.33 score on a scale
Standard Deviation 1.31

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in headaches. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Headaches. [Time Frame: Baseline to Month 3]
Baseline
4.08 score on a scale
Standard Deviation 1.32
Relief From Headaches. [Time Frame: Baseline to Month 3]
Month 1
2.92 score on a scale
Standard Deviation 1.40
Relief From Headaches. [Time Frame: Baseline to Month 3]
Month 2
2.64 score on a scale
Standard Deviation 1.39
Relief From Headaches. [Time Frame: Baseline to Month 3]
Month 3
2.49 score on a scale
Standard Deviation 1.27

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in backaches. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Backaches. [Time Frame: Baseline to Month 3]
Baseline
4.15 score on a scale
Standard Deviation 1.33
Relief From Backaches. [Time Frame: Baseline to Month 3]
Month 1
3.05 score on a scale
Standard Deviation 1.38
Relief From Backaches. [Time Frame: Baseline to Month 3]
Month 2
2.62 score on a scale
Standard Deviation 1.28
Relief From Backaches. [Time Frame: Baseline to Month 3]
Month 3
2.38 score on a scale
Standard Deviation 1.48

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in body aches. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Body Aches. [Time Frame: Baseline to Month 3]
Baseline
3.67 score on a scale
Standard Deviation 1.38
Relief From Body Aches. [Time Frame: Baseline to Month 3]
Month 1
2.44 score on a scale
Standard Deviation 1.31
Relief From Body Aches. [Time Frame: Baseline to Month 3]
Month 2
2.28 score on a scale
Standard Deviation 1.27
Relief From Body Aches. [Time Frame: Baseline to Month 3]
Month 3
2.08 score on a scale
Standard Deviation 1.18

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in bloating. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Bloating. [Time Frame: Baseline to Month 3]
Baseline
4.21 score on a scale
Standard Deviation 1.22
Relief From Bloating. [Time Frame: Baseline to Month 3]
Month 1
3.21 score on a scale
Standard Deviation 1.21
Relief From Bloating. [Time Frame: Baseline to Month 3]
Month 2
2.87 score on a scale
Standard Deviation 1.29
Relief From Bloating. [Time Frame: Baseline to Month 3]
Month 3
2.51 score on a scale
Standard Deviation 1.36

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in gastrointestinal issues. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Gastrointestinal Issues. [Time Frame: Baseline to Month 3]
Baseline
3.97 score on a scale
Standard Deviation 1.38
Relief From Gastrointestinal Issues. [Time Frame: Baseline to Month 3]
Month 1
3.05 score on a scale
Standard Deviation 1.51
Relief From Gastrointestinal Issues. [Time Frame: Baseline to Month 3]
Month 2
2.74 score on a scale
Standard Deviation 1.25
Relief From Gastrointestinal Issues. [Time Frame: Baseline to Month 3]
Month 3
2.26 score on a scale
Standard Deviation 1.29

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in joint or muscle pain. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Joint or Muscle Pain. [Time Frame: Baseline to Month 3]
Baseline
3.46 score on a scale
Standard Deviation 1.52
Relief From Joint or Muscle Pain. [Time Frame: Baseline to Month 3]
Month 1
2.31 score on a scale
Standard Deviation 1.30
Relief From Joint or Muscle Pain. [Time Frame: Baseline to Month 3]
Month 2
2.16 score on a scale
Standard Deviation 1.05
Relief From Joint or Muscle Pain. [Time Frame: Baseline to Month 3]
Month 3
1.90 score on a scale
Standard Deviation 1.10

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in tiredness and fatigue. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Tiredness or Fatigue. [Time Frame: Baseline to Month 3]
Baseline
4.69 score on a scale
Standard Deviation 0.96
Relief From Tiredness or Fatigue. [Time Frame: Baseline to Month 3]
Month 1
3.62 score on a scale
Standard Deviation 1.20
Relief From Tiredness or Fatigue. [Time Frame: Baseline to Month 3]
Month 2
3.26 score on a scale
Standard Deviation 1.39
Relief From Tiredness or Fatigue. [Time Frame: Baseline to Month 3]
Month 3
2.93 score on a scale
Standard Deviation 1.30

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in menstrual symptoms, fatigue, and mood swings. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Reduction in Weight Gain Due to Fluid Retention. [Time Frame: Baseline to Month 3]
Baseline
3.49 score on a scale
Standard Deviation 1.51
Reduction in Weight Gain Due to Fluid Retention. [Time Frame: Baseline to Month 3]
Month 1
2.66 score on a scale
Standard Deviation 1.40
Reduction in Weight Gain Due to Fluid Retention. [Time Frame: Baseline to Month 3]
Month 2
2.31 score on a scale
Standard Deviation 1.27
Reduction in Weight Gain Due to Fluid Retention. [Time Frame: Baseline to Month 3]
Month 3
2.08 score on a scale
Standard Deviation 1.27

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in breast tenderness. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Relief From Breast Tenderness. [Time Frame: Baseline to Month 3]
Month 2
2.20 score on a scale
Standard Deviation 1.30
Relief From Breast Tenderness. [Time Frame: Baseline to Month 3]
Baseline
3.30 score on a scale
Standard Deviation 1.41
Relief From Breast Tenderness. [Time Frame: Baseline to Month 3]
Month 1
2.62 score on a scale
Standard Deviation 1.38
Relief From Breast Tenderness. [Time Frame: Baseline to Month 3]
Month 3
1.93 score on a scale
Standard Deviation 1.18

SECONDARY outcome

Timeframe: Baseline, Month 1, Month 2, Month 3

Survey-based assessment (0-5 scale) of changes in appetite and food cravings. On the scale, 0 = "No symptoms" and 5 = "Severe It interferes with my daily life, and I cancel activities". Lower scores indicate a favourable outcome.

Outcome measures

Outcome measures
Measure
Elix Cycle Balance
n=61 Participants
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Changes in Appetite and Food Cravings. [Time Frame: Baseline to Month 3]
Baseline
3.98 score on a scale
Standard Deviation 1.20
Changes in Appetite and Food Cravings. [Time Frame: Baseline to Month 3]
Month 1
3.03 score on a scale
Standard Deviation 1.31
Changes in Appetite and Food Cravings. [Time Frame: Baseline to Month 3]
Month 2
2.31 score on a scale
Standard Deviation 1.21
Changes in Appetite and Food Cravings. [Time Frame: Baseline to Month 3]
Month 3
2.16 score on a scale
Standard Deviation 1.13

Adverse Events

Elix Cycle Balance

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Elix Cycle Balance
n=68 participants at risk
Elix Cycle Balance supplement Elix Cycle Balance: Each day in the morning and at night in the week prior to the menstruation, the participants will take 6 full droppers of Elix Cycle Balance
Gastrointestinal disorders
Stomach upset
1.5%
1/68 • Number of events 1 • Adverse event data were collected for the duration of the trial. Each participant was monitored for the 3 months they took part in the trial.
All participants were monitored for any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.
General disorders
Headache
1.5%
1/68 • Number of events 1 • Adverse event data were collected for the duration of the trial. Each participant was monitored for the 3 months they took part in the trial.
All participants were monitored for any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.
Social circumstances
Personal Issue
1.5%
1/68 • Number of events 1 • Adverse event data were collected for the duration of the trial. Each participant was monitored for the 3 months they took part in the trial.
All participants were monitored for any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.
Product Issues
No response
5.9%
4/68 • Number of events 4 • Adverse event data were collected for the duration of the trial. Each participant was monitored for the 3 months they took part in the trial.
All participants were monitored for any untoward or unfavorable medical occurrence in a participant, including any abnormal sign (for example, abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the participant's participation in the research, whether or not considered related to the participant's participation in the research.

Additional Information

Patrick Renner

Citruslabs

Phone: 4242450284

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place